What Evidence is Available on Apixaban for the Primary Prevention of Stroke in Patients with Atrial Fibrillation?

This drug information question and answer sheet discusses the use of apixaban (Eliquis) for the primary prevention of stroke in patients with atrial fibrillation

What Evidence is Available on Aldosterone Antagonists for Use in Heart Failure with Preserved Ejection Fraction?

This drug information question and answer sheet discusses the use of aldosterone antagonists for use in heart failure with preserved ejection fraction

Bipolar Disorder: A Pharmacotherapy Management Overview

This home-study CPE activity has been developed to educate pharmacists on bipolar disorder and its management using non-pharmacologic and pharmacologic therapies

Variceal Bleeding from Cirrhosis: A Clinical Review of Causes and Pharmacotherapy Options

This home-study CPE activity has been developed to educate pharmacists on the prevention and treatment of hemorrhagic esophageal varices resulting from cirrhosis

Drug-Induced Cardiotoxicity of Oncological Agents: Monitoring Parameters, Prevention, and Future Chemotherapy

The goal of this article is to educate pharmacists of the impact of cardiotoxicity on chemotherapy regimens including key cancer agents, monitoring parameters, prevention, and the future of chemotherapy

A Pharmacist’s Role in the Prevention and Management of Perioperative Atrial Fibrillation and Flutter

This home-study CPE has been developed to educate pharmacists about recently published guidelines for perioperative atrial fibrillation and flutter management and prevention, and discuss the role a pharmacist can have in the care of these patients

Anti-Platelet Therapy in Acute Coronary Syndromes: Updates in Therapy After Stent Implantation

This home-study CPE activity has been developed to educate pharmacists on updates in anti-platelet therapy after stent implantation

Hyperglycemia and Insulin Management in Critically Ill Patients

Hyperglycemia is a leading cause of increased morbidity and mortality in critically ill diabetic and nondiabetic patients in the ICU. Stricter control should be implemented in this setting in order to reduce mortality as well as other complications caused by hyperglycemia. Because hypoglycemia is associated with an increased risk of adverse effects, the optimal intensity of glucose control has been extensively investigated. Hyperglycemia is better controlled through continuous glucose infusions than with intermittent injections or IV infusions because it is easier to titrate the concentration of insulin to achieve a target glucose range. Pharmacists in acute-care and ambulatory-care settings are able to adjust insulin therapy and educate patients about hypoglycemia or hyperglycemia in order to optimize patient outcomes

Anemia and the Role of the Pharmacist

This home-study CPE has been developed to educate pharmacists and pharmacy technicians about the various types of anemia and their treatments

Comparing the 2013 ACC/AHA & 2014 NLA Dyslipidemia Guidelines and Their Impact on Clinical Decision Making

This home-study CPE activity has been developed to educate pharmacists on the similarities and differences between the 2014 NLA Recommendations for Dyslipidemia Management and the 2013 ACC/AHA Guidelines for Treatment of Blood Cholesterol